未來股份(600532.SH):子公司擬收購Fullerton Healthcare100%股權
格隆匯12月23日丨未來股份(600532.SH)公佈,公司全資子公司上海未郎醫療科技有限公司(“未郎醫療”)有意向以自身或公司控制的關聯方作為收購主體,以現金形式通過直接或間接的方式收購Fullerton Healthcare Corporation Limited(簡稱“標的公司”)100%的普通股股權。
2021年12月23日,公司全資子公司未郎醫療與SIN DAVID及其控制的公司簽署了《合作框架協議》,未郎醫療有意向以自身或公司控制的關聯方作為收購主體,以現金形式通過直接或間接的方式向SIN DAVID 等全部股東收購其持有的標的公司100%普通股股權。
各方初步協商預計全部標的股權的價格約7億-8億新加坡元,標的股權的最終交易對價將以評估機構出具的評估報吿中所確定的評估值為作價基礎,經各方進一步協商確定,其中評估基準日由各方根據擬議交易的進展情況協商確定,最終交易對價待審計、評估及盡職調查完成後以擬議交易各方簽署的最終交易文件為準。
根據初步測算,本次交易可能構成《上市公司重大資產重組管理辦法》規定的重大資產重組。
標的公司於2010年成立於新加坡,是一家綜合醫療服務平台。業務目前已覆蓋新加坡、菲律賓、印度尼西亞、馬來西亞、中國(包括香港特別行政區)、巴布亞新幾內亞等國家及地區,擁有500多家自營醫療中心,1100多名醫療專家,6800多名員工,近12,000個醫療網絡合作夥伴,為客户提供便捷、優質的醫療健康服務。
本次收購符合公司的戰略發展方向,有助於加快公司業務轉型,為公司在醫療服務行業進一步發展奠定良好基礎;有助於進一步提升上市公司的綜合競爭能力和後續發展能力,增強上市公司的抗風險能力和持續經營能力。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.